top of page

Minor League JDA

The Minor League Joint Drug Agreement outlines the policies governing drug testing, prevention, and education for Minor League players. Jointly negotiated by the MLBPA and Major League Baseball, the agreement is designed to protect the integrity of the game while prioritizing player health and fairness.

It sets clear standards for testing procedures, disciplinary measures, and ongoing efforts to promote a clean and competitive sport.

This resource can be downloaded as a PDF by clicking below.

Download Now
Related Media

Follow Us

  • X
  • Instagram
  • Facebook
  • Youtube
  • LinkedIn
MLBPA Placeholder.avif

11 Additional Players Become XX(B) Free Agents

The 11 players listed below have resolved option decisions in their Uniform Player Contracts through Oct. 30 and joined the list of XX(B) free agents.

October 30, 2026

MLBPA Placeholder.avif

144 Players Become XX(B) Free Agents

144 players were declared XX(B) free agents at the conclusion of the 2026 season. Additional Players may become XX(B) free agents after their options are resolved or pending option decisions in their Uniform Player Contracts. 

October 29, 2026

MLBPA Placeholder.avif

Pete-Crow Armstrong, Chris Bassitt, and Former Player David ...

Pete Crow-Armstrong has been named overall Player of the Year and NL Outstanding Player, while Yordan Álvarez took home the AL Outstanding Player and Comeback Player of the Year awards in the 2026 Players Choice Awards voting.

October 28, 2026

Latest Press Releases

Stay up to date with the latest announcements, initiatives, and official updates from the MLBPA.

MLBPA

MLBPA

MLBPA

MLBPA

Media Inquiries

For press inquiries, interview requests, or additional information about the MLBPA.

bottom of page